TECHWIRE 30
(CIX: WRAL30)  1,147.54    (0 %)  Updated: 08:10 PM EST, Nov 26 2014
(NQ: Apple)  119.00    (0 %)  Updated: 08:10 PM EST, Nov 26 2014
(NY: QUINTILES)  57.96    (0 %)  Updated: 06:40 PM EST, Nov 26 2014
(OP: BASF SE)  94.20    (0 %)  Updated: 05:20 PM EST, Nov 26 2014
(NQ: BioCryst)  11.38    (0 %)  Updated: 08:10 PM EST, Nov 26 2014
(NQ: BioDelivery)  15.80    (0 %)  Updated: 08:10 PM EST, Nov 26 2014
(NQ: CEMP)  14.54    (0 %)  Updated: 08:10 PM EST, Nov 26 2014
(NQ: Cisco Systems)  27.43    (0 %)  Updated: 08:10 PM EST, Nov 26 2014
(NQ: Cree)  36.74    (0 %)  Updated: 08:10 PM EST, Nov 26 2014
(NQ: DARA)  0.78    (0 %)  Updated: 08:10 PM EST, Nov 26 2014
(NY: EMC CORPORATION)  30.04    (0 %)  Updated: 06:40 PM EST, Nov 26 2014
(NQ: Extreme Networks)  3.63    (0 %)  Updated: 08:10 PM EST, Nov 26 2014
(NQ: FB)  77.62    (0 %)  Updated: 08:10 PM EST, Nov 26 2014
(NY: GLAXOSMITHKLINE)  46.52    (0 %)  Updated: 06:40 PM EST, Nov 26 2014
(NQ: GOOG)  540.37    (0 %)  Updated: 08:10 PM EST, Nov 26 2014
(NY: IBM)  161.95    (0 %)  Updated: 06:40 PM EST, Nov 26 2014
(NY: LH)  102.15    (0 %)  Updated: 06:40 PM EST, Nov 26 2014
(OP: Lenovo Group)  27.89    (0 %)  Updated: 05:20 PM EST, Nov 26 2014
(NY: MRK)  59.75    (0 %)  Updated: 06:40 PM EST, Nov 26 2014
(NQ: Microsoft Corp)  47.75    (0 %)  Updated: 08:10 PM EST, Nov 26 2014
(NQ: NTAP)  42.70    (0 %)  Updated: 08:10 PM EST, Nov 26 2014
(NY: NOVARTIS AG)  95.56    (0 %)  Updated: 06:40 PM EST, Nov 26 2014
(OP: Novozymes A/S)  45.82    (0 %)  Updated: 05:20 PM EST, Nov 26 2014
(NY: PFIZER)  31.10    (0 %)  Updated: 06:40 PM EST, Nov 26 2014
(NQ: Pozen)  9.00    (0 %)  Updated: 08:10 PM EST, Nov 26 2014
(NY: RED HAT)  62.10    (0 %)  Updated: 06:40 PM EST, Nov 26 2014
(NQ: BBRY)  10.48    (0 %)  Updated: 08:10 PM EST, Nov 26 2014
(NQ: Salix)  103.25    (0 %)  Updated: 08:10 PM EST, Nov 26 2014
(NQ: SQI)  15.25    (0 %)  Updated: 08:10 PM EST, Nov 26 2014

Posts tagged “SciQuest”

July 31

Premium Lock Inside SciQuest earnings: 'Elephant hunting' triggers 'lumpy' results

In a conference call to discuss second-quarter earnings, SciQuest CEO Stephen Wiehe is asked about the "volatility" in its results and what he is telling investors. Wiehe says "elephant hunting" big deals is a major reason earnings are "lumpy," but says more products may smooth out future results.

Stephen Wiehe Stephen Wiehe

Updated March 28

Premium Lock SciQuest shares dip then rally after pricing of 3M share offering

SciQuest SciQuest shares dropped some 5 percent Thursday after the company set a price of $26.75 per share in an offering of some 3 million. SciQuest dropped $1.25 from Wednesday's close of $26.98 before rallying. On Friday, SciQuest traded at $30.41.

March 25

Premium Lock SciQuest looking to raise $90M in stock offering

SciQuest SciQuest is rolling out a 3 million share offering today and says it will use the proceeds as working capital plus "general corporate purposes." Underwriters have the option to purchase another 450,000 shares.

February 25

Premium Lock SciQuest lands RTI; BioCryst flu treatment advances; DARA drug wins orphan status; OIN adds new member

Bulldog In regional technology and life science news: SciQuest has landed RTI International as a customer. BioCryst's influenza treatment advances; Open Invention Network adds VIA Technologies; and a drug from DARA BioSciences receives orphan drug status.

February 6

Premium Lock New customers, stronger sales boost SciQuest's 4Q results

SciQuest The Cary company, whose software automates spending and purchasing functions for companies, narrowed its net loss to $1.2 million compared to a $2.4 million net loss in the prior year period. The company said the results were expected and were related to costs associated with acquisitions and stock-based compensation.

January 13

Premium Lock Alcatel mulls sale; McCrory at NCTA; Compuware board; SciQuest conference; Novartis-Japan probe; Sanofi $700M drug buy; Red Hat-backed case to high court

Bulldog In our Bulldog blog's tech and life science news update: Alcatel-Lucent considers hardware sale; N.C. governor to address NCTA event; Compuware shakes up its board to avoid proxy fight; SciQuest sets annual conference with hockey hero Mike Eruzione as a speaker; Novartis faces inquiry over drug in Japan; Sanofi pays $700M for drug; Red Hat-backed patent case appeal to be heard by the Supreme Court.

November 5, 2013

Premium Lock SciQuest's 3Q loss widens to $1.8M as firm digests recent acquisitions

SciQuest Electronic purchasing and spend management software company SciQuest (NASDAQ:SQI) reported a third quarter loss of $1.8 million, which the company attributed to the expected impact of its recent acquisitions.

Updated September 3, 2013

Premium Lock SciQuest acquires 'complex sourcing' software firm CombineNet for $43M

SciQuest SciQuest makes another acquisition, this time bringing into the fold CombineNet. Read why SciQuest made the move.

August 2, 2013

Premium Lock Losing two state customers, SciQuest revises 2013 guidance

SciQuest SciQuest CEO Stephen Wiehe said Colorado and Oregon are the only states that have not followed through on implementing the software after initially signing up. He said the risk other states would do the same is low.

August 2, 2013

Premium Lock SciQuest's 2Q revenue tops $21M

SciQuest SciQuest (NASDAQ:SQI) saw its second quarter revenue reach $21.2 million, up 34 percent from a year ago, as two acquisitions made last year made contributions to the company's sales.

Updated July 15, 2013

Premium Lock SciQuest: Growth drives decision to move headquarters to Morrisville

SciQuest SciQuest, a Cary-based provider of e-procurement services to clients worldwide, is adding space in moving its headquarters to a new office building in Morrisville next year.

May 23, 2013

Premium Lock SciQuest board names CEO Wiehe as its chairman

Stephen Wiehe Stephen Wiehe, the top executive at SciQuest since 2001, succeeds Noel Fenton, the formal board chair, did not stand for re-election.

May 22, 2013

Premium Lock SciQuest hires veteran executive to lead sales efforts

SciQuest Jeffrey Martini is leaving the e-procurement services firm after eight years. He will be replaced by Douglas Keister.

Tags: SciQuest
May 10, 2013

Premium Lock As Quintiles' Gillings rings opening bell, SciQuest CEO recalls the feeling

Dennis Gillings, who started Quintiles in a trailer more than 30 years ago, rings the opening bell on the New York Stock Exchange today to celebrate the giant's return to public markets. Stephen Wiehe, who led SciQuest through a similar private-to-public Odyssey, recalls the "humbling" ringing bell honor.

Stphen Wiehe claps after opening Nasdaq Stphen Wiehe claps after opening Nasdaq

Updated May 2, 2013

Premium Lock SciQuest reports 1Q loss, cites impacts of acquisitions

SciQuest SciQuest said its financial results were impacted by two acquisitions it made last year.

Updated March 6, 2013

Premium Lock SciQuest CEO Wiehe's 2012 executive compensation tops $1.9M

Stephen Wiehe Stephen Wiehe, who joined the company in 2001, could earn $316,000 in bonuses this year. The Cary e-procurement firm is forecasting 30 percent growth this year.

February 8, 2013

Premium Lock SciQuest forecasts 30% revenue jump in 2013

SciQuest Bolstered by continuing growth and two acquisitions made in 2012, Cary-based SciQuest is projecting a 30 percent surge in revenue this year to at least $86 million.

January 15, 2013

Premium Lock U. of Wisconsin picks SciQuest for procurement services

SciQuest The University of Wisconsin at Madison is the latest higher education institution to contract with Cary-based SciQuest for procurement services.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith

OUR INSIDERS

Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Scroll